Desk
Blogs
Short essays on radiation techniques, when travel is justified, and the records we ask for before anyone books a ticket. This is the only editorial surface on the site.

Orthopedics · 29 September 2026
Knee Replacement Surgery in India
Total, partial, revision and robotic knee replacement in India: who needs surgery, how the operation is done, recovery, risks and GAF planning ranges for international patients.

Medical Oncology · 28 September 2026
Colon Cancer Targeted Therapy in India: RAS, BRAF, HER2 and EGFR
When colon cancer targeted therapy is appropriate: RAS, BRAF V600E, HER2, KRAS G12C, cetuximab, bevacizumab, later-line options and GAF planning ranges.

Medical Oncology · 28 September 2026
Colon Cancer Immunotherapy in India: MSI-H, Pembrolizumab and Nivolumab
When colon cancer immunotherapy is appropriate: MSI-H/dMMR testing, pembrolizumab, nivolumab plus ipilimumab, immune-related side effects and GAF planning ranges.

Medical Oncology · 28 September 2026
Colon Cancer Chemotherapy in India: FOLFOX, CAPOX and FOLFIRI
When colon cancer needs chemotherapy: FOLFOX vs CAPOX, 3 vs 6 months, FOLFIRI, FOLFOXIRI, MSI/MMR immunotherapy and GAF planning ranges.

Surgical Oncology · 28 September 2026
Stage 4 Colon Cancer Treatment in India: Metastatic Care, Surgery and Targeted Therapy
Metastatic colon cancer: resectable vs unresectable disease, conversion therapy, FOLFOX/FOLFIRI, MSI/MMR immunotherapy, liver surgery and CRS/HIPEC.

Surgical Oncology · 28 September 2026
Stage 3 Colon Cancer Treatment in India: Surgery, FOLFOX and CAPOX
Node-positive colon cancer: surgery plus adjuvant FOLFOX or CAPOX, 3 versus 6 months, MSI/MMR testing, and why Stage 3 is not Stage 4.

Surgical Oncology · 28 September 2026
Stage 2 Colon Cancer Treatment in India: Surgery, High-Risk Features and Chemotherapy
T3 and T4 colon cancer: when surgery alone is enough, which high-risk features prompt adjuvant chemotherapy, and why MSI/MMR status changes the discussion in India.

Surgical Oncology · 28 September 2026
Stage 1 Colon Cancer Treatment in India: Endoscopic Removal vs Colectomy
T1 and T2 colon cancer: when a malignant polyp can stay with colonoscopy, when partial colectomy is needed, and why chemotherapy is usually not routine after Stage 1.

Surgical Oncology · 28 September 2026
Colon Cancer Surgery in India: Colectomy, Approaches and Recovery
Hemicolectomy, anastomosis and stomas: how tumour location decides the operation, when laparoscopic or robotic surgery is appropriate, and GAF planning ranges for colectomy in India.

Medical Oncology · 28 September 2026
Hormone Therapy for Prostate Cancer: ADT, Medicines, Side Effects and Duration
ADT lowers testosterone; ARPIs block the receptor. How long treatment lasts, what side effects to plan for, and why duration depends on stage rather than one drug name.

Medical Oncology · 28 September 2026
PSMA PET Scan for Prostate Cancer: Uses, Preparation and Cost in India
PSMA PET is molecular imaging, not a better CT. When EAU recommends it, why it does not replace MRI or biopsy, how to prepare, and why Indian prices need a written quotation.

Medical Oncology · 28 September 2026
Lutetium-177 PSMA Therapy in India: Eligibility, Procedure, Cost and Side Effects
Lu-177 PSMA is radioligand therapy, not chemotherapy. Who may be eligible, how 7.4 GBq cycles work, side effects, and why Indian prices need an itemised quotation.
Page 1 of 5Next